Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Leukemia 40Myelodysplastic Syndromes 38Leukemia, Myeloid, Acute 34Lymphoma 31Leukemia, Lymphocytic, Chronic, B-Cell 31Lymphoma, Non-Hodgkin 28Hodgkin Disease 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Multiple Myeloma 25Myeloproliferative Disorders 21Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Follicular 21Lymphoma, B-Cell, Marginal Zone 21Lymphoma, Mantle-Cell 20Lymphoma, Large-Cell, Immunoblastic 17Burkitt Lymphoma 17Primary Myelofibrosis 16Neoplasms, Plasma Cell 16Leukemia, Myeloid, Accelerated Phase 16Congenital Abnormalities 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15Lymphoma, T-Cell, Cutaneous 14Leukemia, Myelomonocytic, Chronic 14Leukemia, Myeloid, Chronic-Phase 14Graft vs Host Disease 14Blast Crisis 13Hematologic Neoplasms 12Waldenstrom Macroglobulinemia 11Sezary Syndrome 11Lymphoma, Extranodal NK-T-Cell 11

Interventions

Voriconazole 3posaconazole 2Fluconazole 2Caspofungin 2liposomal amphotericin B 1Standard of Care 1ProMune 1Lymphatic Irradiation 1Levofloxacin 1Cyclosporine 1Antilymphocyte Serum 1Amphotericin B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mycoses × Antilymphocyte Serum × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡